| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.04 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |